Morgan Stanley’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-1,392,136
| Closed | -$23.6M | – | 6925 |
|
|
2014
Q4 | $23.6M | Buy |
1,392,136
+1,068,058
| +330% | +$18.1M | 0.01% | 1344 |
|
|
2014
Q3 | $3.86M | Buy |
324,078
+240,150
| +286% | +$2.86M | ﹤0.01% | 2856 |
|
|
2014
Q2 | $473K | Buy |
83,928
+16,748
| +25% | +$94.4K | ﹤0.01% | 4616 |
|
|
2014
Q1 | $246K | Sell |
67,180
-704,285
| -91% | -$2.58M | ﹤0.01% | 5012 |
|
|
2013
Q4 | $2.59M | Buy |
771,465
+1,737
| +0.2% | +$5.84K | ﹤0.01% | 3184 |
|
|
2013
Q3 | $3.26M | Buy |
769,728
+692,612
| +898% | +$2.93M | ﹤0.01% | 2832 |
|
|
2013
Q2 | $354K | Buy |
+77,116
| New | +$354K | ﹤0.01% | 4500 |
|